Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-18T11:07:43.706Z Has data issue: false hasContentIssue false

Analysis of the early life treatment to kids with a halogenated methane analogue additive on immunoglobulin G levels

Published online by Cambridge University Press:  19 April 2013

L. Abecia
Affiliation:
Estación Experimental del Zaidín (CSIC), Profesor Albareda, 1. 18008 Granada, Spain
A. Clemente
Affiliation:
Estación Experimental del Zaidín (CSIC), Profesor Albareda, 1. 18008 Granada, Spain
A. I. Martín-García
Affiliation:
Estación Experimental del Zaidín (CSIC), Profesor Albareda, 1. 18008 Granada, Spain
G. Martínez
Affiliation:
Estación Experimental del Zaidín (CSIC), Profesor Albareda, 1. 18008 Granada, Spain
C. J. Newbold
Affiliation:
IBERS, Aberystwyth University, Aberystwyth, SY23 3DA, United Kingdom
D. R. Yáñez-Ruiz
Affiliation:
Estación Experimental del Zaidín (CSIC), Profesor Albareda, 1. 18008 Granada, Spain
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2013 

In ruminants, homeostasis between the rumen microbiome and the host is in a significant extent immunologically driven. Some studies have reported an immunomodulation of the Archaea group in the rumen after specific vaccination( Reference Williams, Popovski and Rea 1 ). However, no information is available on the transfer of IgG from the mother and the development of immunity in the offspring when an antimicrobial intervention is applied in early life. The aim of this work was to study the effect of treating goats and their offspring from early life with an antimethanogenic compound (bromochloromethane, BCM) on IgG levels in serum (offspring) and milk (mothers). The long-term effect on the offspring was also assessed. Two experimental groups of treated (M+) and non-treated (M-) lactating goats (n = 9 per group) were used to analyze the effect of adding BCM in the diet. Milk and blood samples were taken one day after birth (P1), 21 days later (P2) and at weaning (P3). One kid per mother in both groups was treated with BCM (k+) from 7 days of age while the other was untreated (k−), resulting in four experimental groups: M+k+, M+k−, M-k+ and M-k−. Blood samples from kids were collected at 3 times: at weaning (P3), 1 month after weaning with all kids separated by treatment (P4) and 2 months later when the kids were all grouped together and the BCM treatment had stopped (P5). In the transition from colostrum to mature milk, IgG levels decreased sharply (P < 0.0001) from P1 to P2 (5859 vs 209 μg/ml; Fig. 1) and remained stable to weaning (263). No significant effect of BCM treatment on IgG levels of mothers´ milk was observed. IgG levels in goats' serum were unaffected (7634 μg/ml) by treatment or period. On the other hand, in kids, an expected increase in IgG levels in serum with age was observed (3903, 5070 and 9663 μg/ml for P3, P4 and P5, respectively). The treatment with BCM resulted in higher (P < 0.05) levels of IgG in the serum of M-k+ kids one month after weaning, although this difference did not persist three months later. These results show that an antimicrobial treatment applied in early life may have an impact on the IgG response of the young ruminant. The levels of specific Ig to some microbial groups may provide more insight of the mechanisms involved in such immune response.

Figure 1. IgG levels in colostrum and milk (μg/ml).

Figure 2. IgG levels in kids' serum (μg/ml).

This study was funded by the European Commission (Marie Curie Reintegration Grant 224816–METANORUMEN). Dr. L. Abecia acknowledges research contract JAE-Doc from CSIC.

References

1. Williams, YJ, Popovski, S, Rea, SM et al. (2009) Appl Environ Microbiol 75, 18601866.CrossRefGoogle Scholar
Figure 0

Figure 1. IgG levels in colostrum and milk (μg/ml).

Figure 1

Figure 2. IgG levels in kids' serum (μg/ml).